Merck recalls 276,000 pill bottles
Merck & Co. has recalled two chemotherapy products because of cracked caps, including one it manufactures for Novartis’ Sandoz.
The company estimates about 1,100 bottles out of 276,000 distributed units of of oral drug Temodar and its generic temozolomide were put on the market with a faulty child-resistant closure. It said consumers who find broken packaging should contact Merck for a replacement cap. Patients can continue to take the drugs.
The capsules were distributed in 5- and 14-count brown glass bottles with white plastic tops since July 2013. No injuries have been reported so far.
Merck & Co. markets Temodar itself but makes temozolomide on behalf of Sandoz.
